Literature DB >> 32036510

Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease.

Samaa Shama1,2,3, Wanqing Liu4,5,6.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease characterized with the spectrum of hepatic steatosis, inflammation, and fibrosis. The etiology of NAFLD remains incompletely understood. Numerous studies have implied that the gut microbiota (GM) is involved in the development of NAFLD, as it particularly mediating the interaction between nutrient intake and the gut-liver function. Meanwhile, the omega-3 and omega-6 polyunsaturated fatty acids (n-3/n-6 PUFA) as essential fatty acids have been linked to NAFLD. Increasing studies in the past decades have indicated that there is a reciprocal interaction between GM and n-3/n-6 PUFA, which may be underlying at least in part, the pathogenesis of NAFLD. In this review, we will discuss: (1) How GM is linked to NAFLD by interacting with various nutrients; (2) How imbalanced dietary n-3/n-6 PUFA is linked to NAFLD; (3) How n-3/n-6 PUFA may affect the GM balance, leading to altered nutrients release to the liver; and (4) How GM may modify ingested n-3/n-6 PUFA and alter their absorption, bioavailability, and biotransformation.

Entities:  

Keywords:  Gut microbiota; NAFLD; Nutrient; n-3/n-6 PUFA

Mesh:

Substances:

Year:  2020        PMID: 32036510      PMCID: PMC7145364          DOI: 10.1007/s10620-020-06117-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Mechanism of amino acid-induced skeletal muscle insulin resistance in humans.

Authors:  Michael Krebs; Martin Krssak; Elisabeth Bernroider; Christian Anderwald; Attila Brehm; Martin Meyerspeer; Peter Nowotny; Erich Roth; Werner Waldhäusl; Michael Roden
Journal:  Diabetes       Date:  2002-03       Impact factor: 9.461

2.  A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota.

Authors:  Henry Watson; Suparna Mitra; Fiona C Croden; Morag Taylor; Henry M Wood; Sarah L Perry; Jade A Spencer; Phil Quirke; Giles J Toogood; Clare L Lawton; Louise Dye; Paul M Loadman; Mark A Hull
Journal:  Gut       Date:  2017-09-26       Impact factor: 23.059

Review 3.  Biochemical and physiological function of stearoyl-CoA desaturase.

Authors:  Chad M Paton; James M Ntambi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-09       Impact factor: 4.310

4.  Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity.

Authors:  Gaurav Gupta; Forough Khadem; Jude E Uzonna
Journal:  Cytokine       Date:  2018-09-18       Impact factor: 3.861

5.  Potent PPARα activator derived from tomato juice, 13-oxo-9,11-octadecadienoic acid, decreases plasma and hepatic triglyceride in obese diabetic mice.

Authors:  Young-il Kim; Shizuka Hirai; Tsuyoshi Goto; Chie Ohyane; Haruya Takahashi; Taneaki Tsugane; Chiaki Konishi; Takashi Fujii; Shuji Inai; Yoko Iijima; Koh Aoki; Daisuke Shibata; Nobuyuki Takahashi; Teruo Kawada
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

6.  Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.

Authors:  Shoji Yamada; Nobuhiko Kamada; Takeru Amiya; Nobuhiro Nakamoto; Toshiaki Nakaoka; Masaki Kimura; Yoshimasa Saito; Chieko Ejima; Takanori Kanai; Hidetsugu Saito
Journal:  BMC Gastroenterol       Date:  2017-11-29       Impact factor: 3.067

7.  Health implications of high dietary omega-6 polyunsaturated Fatty acids.

Authors:  E Patterson; R Wall; G F Fitzgerald; R P Ross; C Stanton
Journal:  J Nutr Metab       Date:  2012-04-05

8.  Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.

Authors:  Yvonne Ritze; Gyöngyi Bárdos; Anke Claus; Veronika Ehrmann; Ina Bergheim; Andreas Schwiertz; Stephan C Bischoff
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

9.  Effect of n-3 fatty acids on the expression of inflammatory genes in THP-1 macrophages.

Authors:  Bénédicte Allam-Ndoul; Frédéric Guénard; Olivier Barbier; Marie-Claude Vohl
Journal:  Lipids Health Dis       Date:  2016-04-05       Impact factor: 3.876

Review 10.  The role of the microbiome in NAFLD and NASH.

Authors:  Aleksandra A Kolodziejczyk; Danping Zheng; Oren Shibolet; Eran Elinav
Journal:  EMBO Mol Med       Date:  2019-02       Impact factor: 12.137

View more
  9 in total

Review 1.  Omega-3 Fatty Acids and Their Interaction with the Gut Microbiome in the Prevention and Amelioration of Type-2 Diabetes.

Authors:  Manoj Kumar; Namrata Pal; Poonam Sharma; Manoj Kumawat; Devojit Kumar Sarma; Bilkees Nabi; Vinod Verma; Rajnarayan R Tiwari; Swasti Shubham; Bahram Arjmandi; Ravinder Nagpal
Journal:  Nutrients       Date:  2022-04-21       Impact factor: 6.706

Review 2.  Effects of Non-Polar Dietary and Endogenous Lipids on Gut Microbiota Alterations: The Role of Lipidomics.

Authors:  Konstantinos Tsiantas; Spyridon J Konteles; Eftichia Kritsi; Vassilia J Sinanoglou; Thalia Tsiaka; Panagiotis Zoumpoulakis
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

3.  Physicochemical Properties and Sensory Acceptability of a Next-Generation Functional Chocolate Added with Omega-3 Polyunsaturated Fatty Acids and Probiotics.

Authors:  Paulinna Faccinetto-Beltrán; Andrea R Gómez-Fernández; Norma E Orozco-Sánchez; Esther Pérez-Carrillo; Luis Martín Marín-Obispo; Carmen Hernández-Brenes; Arlette Santacruz; Daniel A Jacobo-Velázquez
Journal:  Foods       Date:  2021-02-04

Review 4.  Nutritional Viewpoints on Eggs and Cholesterol.

Authors:  Michihiro Sugano; Ryosuke Matsuoka
Journal:  Foods       Date:  2021-02-25

Review 5.  Omega-3 Polyunsaturated Fatty Acids and the Intestinal Epithelium-A Review.

Authors:  Luke A Durkin; Caroline E Childs; Philip C Calder
Journal:  Foods       Date:  2021-01-19

6.  Alteration of Bile Acids and Omega-6 PUFAs Are Correlated With the Progression and Prognosis of Drug-Induced Liver Injury.

Authors:  Shuang Zhao; Haoshuang Fu; Tianhui Zhou; Minghao Cai; Yan Huang; Qinyi Gan; Chenxi Zhang; Cong Qian; Jiexiao Wang; Zhenglan Zhang; Xiaolin Wang; Xiaogang Xiang; Qing Xie
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786

7.  Short-term supplementation with ω-3 polyunsaturated fatty acids modulates primarily mucolytic species from the gut luminal mucin niche in a human fermentation system.

Authors:  Charlène Roussel; Sara Anunciação Braga Guebara; Pier-Luc Plante; Yves Desjardins; Vincenzo Di Marzo; Cristoforo Silvestri
Journal:  Gut Microbes       Date:  2022 Jan-Dec

8.  Correlations between α-Linolenic Acid-Improved Multitissue Homeostasis and Gut Microbiota in Mice Fed a High-Fat Diet.

Authors:  Xiaoyu Gao; Songlin Chang; Shuangfeng Liu; Lei Peng; Jing Xie; Wenming Dong; Yang Tian; Jun Sheng
Journal:  mSystems       Date:  2020-11-03       Impact factor: 6.496

Review 9.  The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage.

Authors:  Julio Plaza-Díaz; Patricio Solís-Urra; Fernando Rodríguez-Rodríguez; Jorge Olivares-Arancibia; Miguel Navarro-Oliveros; Francisco Abadía-Molina; Ana I Álvarez-Mercado
Journal:  Int J Mol Sci       Date:  2020-11-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.